Everything Jim Cramer said about the stock market on 'Mad Money,' including investing next week, foreign drug stocks, Conagra earnings and GoodRx CEO

Jim Cramer breaks down the Trump administration's consideration to stop U.S. investing in Chinese businesses, recommends foreign pharmaceutical companies, reviews Conagra's earnings report and interview GoodRx CEO Doug Hirsch.